Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
23 June 2017
Deals | France | M&A
Gide advises Debiopharm Holding, shareholder of Eurosic, in the context of the friendly business combination between Gecina and Eurosic, consisting in the acquisition of all the securities of Eurosic by Gecina.
This transaction is supported by Eurosic's six main shareholders (Batipart, Covea, ACM, Prédica, Debiopharm and La Tricogne), representing 94.8% of the capital on a diluted basis, under firm agreements signed to sell blocks of securities and undertakings to tender securities for the mandatory public offer that will be submitted once the blocks have been acquired.
The Gide team comprised Antoine Tézenas du Montcel (partner) and Anne Chiappa.
De Pardieu Brocas Maffei advised Batipart; Darrois Villey Maillot Brochier advised Eurosic and Cleary Gottlieb Steen & Hamilton advised Eurosic.
